Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Children's Advil

This article was originally published in The Tan Sheet

Executive Summary

Children's Advil: Receives OTC marketing approval on June 28 for temporary relief of fever and minor aches and pains due to colds, flu, sore throat, headache, and toothache for children ages 2-11. The pediatric suspension formula has been "approvable" since April 25. Whitehall-Robins has not announced a launch date; however, the company will likely work quickly since McNeil's new Children's Motrin Drops and Junior Strength Motrin Caplets are scheduled to hit stores in August ("The Tan Sheet" June 17, p. 1)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085529

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel